AMSA Pharm-free Scorecard 2010
B Boston University School of Medicine
City: Boston State: MA
Commentary:

Summary: This institution now has a comprehensive policy that provides strong to model policies in almost all domains. Language on consulting relationships is clear and detailed, allowing it to serve as a model for other institutions. The institution also incorporates a COI curriculum into their training of students.  Areas for improvement include public disclosure of conflicts of interest as this was not found in any submitted policies. Other such areas include implementation of public disclosure and the complete elimination of drug samples.  BU's grade is now a B.

Demographics: The major training sites for students are Boston Medical Center, Boston VA Healthcare System, and Mount Auburn Hospital. Submitted policies apply to all these institutions.

 

This institution's evaluation was last updated: 7/4/2013



Gifts & Meals 3 Faculty and clinicians may not accept any form of personal gift, and food directly or indirectly funded by industry may not be provided on-site.
Consulting relationships 3 Model policy. Consulting relationships must be specified in a written contract, with compensation at fair market value for bona fide services. Consulting contracts must be approved by the faculty member's Department Chair prior to implementation.
Industry-funded speaking relationships 2 Speakers bureau participation is allowed with conditions, including full faculty control of content presented and fair-market compensation. Speaking relationships must also be approved by department chairs.
Disclosure 2 Internal disclosure financial interests with industry must be disclosed on an annual basis.
Pharmaceutical samples 2 Pharmaceutical samples are allowed if they are received and dispensed by the institutional pharmacy. Individual faculty and clinitians are not allowed to receive, dispense, sell, or use pharmaceutical samples (for themselves or family members).
Purchasing & Formularies 3 Employees are required to disclose conflicts of interest based on personal relationships and those of immediate family. Significant financial interest is defined as being a management-level employee or higher, or ownership of more than 5% of an entity. Individuals with a conflict of interest must refrain from participating in considerations by the institution of business or financial relationships with relevant entities.
Industry Sales Representatives 2 Industry interactions with trainees is banned unless for device education with an instructor present. Industry representatives are not allowed in patient care areas and must visit faculty and clinicians by appointment only. Exception is provided for access to patient care areas if faculty or clinicians request industry representative presence during procedures involving devices.
On-campus Education 2 On-site educational events must meet ACCME standards, regardless of whether CME credit is awarded. Funds must be channeled through the Office of Continuing Medical Education, with content, speaker, forum, and management of conflicts of interest controlled by the course director. Aside from acknowledgement of funding source, no marketing, detailing, or other forms of vendor advertising are allowed.
Attendance at Industry-Sponsored Lectures & Meetings Off-Campus 3 Faculty are prohibited from accepting compensation or funding for travel simply for attending a continuing medical education or other instructional event. Faculty are further explicitly banned from receiving compensation for listening to any sales presentation by a company representative.
Industry Support for Scholarships & Funds for Trainees 3 Direct industry funding of non-research scholarship or training is not allowed. In the case of scholarships, indirect industry funding through professional organizations or non-profit organizations is allowed if recipients are selected by a peer-review process, without quid pro quo, approved by a Department Chair or Vice President, and if funds are paid to a corporation.
Medical school curriculum 3 BU has implemented a COI curriculum that includes a pre and post-test survey of student opinions.
Do the policies specify an oversight mechanism? Yes Department Chairs are specified as reporting parties to the Chief Complaince Officer, Chief Medical Officer, and the Provost. A standing committee is also specified as the mechanism for investigations and enforcement measures related to policy violations.
Are there explicit sanctions for noncompliance? Yes Disciplinary actions for violation of institutional policies are specified, including possible financial penalities and possibly termination for repeat violations.
What the results mean...
3Model policy
2Good progress toward model policy
1No policy, or policy unlikely to have a substantial effect on behavior
0Did not report
N/APolicy not relevant to this institution (e.g., does not make purchasing decisions)